1. |
Shields JA, Shields CL, Honavar SG, et al.Clinical variations and complications of Coats disease in 150 cases:the 2000 Sanford Gifford Memorial Lecture[J].Am J Ophthalmology, 2001, 131(5):561-571.
|
2. |
Sun Y, Jain A, Moshfeghi DM.Elevated vascular endothelial growth factor levels in Coats disease:rapid response to pegaptanib sodium[J].Graefe's Arch Clin Exp Ophthalmol, 2007, 245(9):1387-1388.
|
3. |
Zhang H, Liu ZL. Increased nitric oxide and vascular endothelial growth factor levels in the aqueous humor of patients with coats' disease[J]. J Ocul Pharmacol Ther, 2012, 28(4):397-401.
|
4. |
Wang KY, Cheng CK. A combination of intravitreal bevacizumab injection with tunable argon yellow laser photocoagulation as a treatment for adult-onset Coats'disease[J]. J Ocul Pharmacol Ther, 2011, 27(5):525-530.
|
5. |
Lin CJ, Hwang JF, Chen YT, et al. The effect of intravitreal bevacizumab in the treatment of Coats disease in children[J].Retina, 2010, 30(4):617-622.
|
6. |
高磊, 李元彬, 王海燕, 等.玻璃体腔联合注药治疗晚期Coats病一例[J].中华眼底病杂志, 2010, 26(3):287-288.
|
7. |
杨琼, 魏文斌, 刘月明, 等.单纯玻璃体腔注射雷珠单抗及其联合其他方法治疗3期以上Coats病的疗效观察[J].中华眼底病杂志, 2014, 30(5):462-465.
|